Tacrolimus versus cyclosporine A for prevention of graft versus host disease after stem cell transplantation

  • Protocol
  • Intervention

Authors


Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To examine the effectiveness of tacrolimus compared to cyclosporine A (CsA) with regard to overall survival, relapse-free survival, prophylaxis of acute graft versus host disease (GVHD) and incidence of cGVHD in patients receiving allogeneic hematopoietic stem cell transplantation (HSCT).